BioCentury | Jun 2, 2017
Product Development

Ears wide open

...are intended to treat their respective indications. (A) Spiral Therapeutics Inc. has an option to BN201...
BioCentury | Mar 31, 2017
Company News

Bionure Farma, Spiral Therapeutics deal

...option to acquire exclusive, worldwide rights to Bionure’s preclinical serum/glucocorticoid regulated kinase 2 (SGK2) agonists BN201...
...receive up to $4.9 million in milestones, plus royalties. Spiral said that Bionure’s lead compound, BN201...
...Farma S.L. , Menlo Park, Calif. Spiral Therapeutics Inc. , San Francisco, Calif. Business: Other Alex Himes BN201 Bionure...
BioCentury | Dec 19, 2013
Translation in Brief

Translational tidbits

...Inc. Myelin Repair Foundation Autoimmune disease Undisclosed Partnership to evaluate the neuroprotective capabilities of Bionure's BN201...
BioCentury | Nov 11, 2013
Company News

Bionure, Myelin Repair Foundation deal

...Bionure partnered with the foundation to evaluate the neuroprotective capabilities of Bionure's BN201 in promoting myelin...
Items per page:
1 - 4 of 4